99mtc-mibi
Small moleculeexperimentalImaging agent
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Mar 1, 2010 (NCT00984191)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 99-technetium
Oral
No
Parenteral
No
Topical
No
Also known as
- 99mtc-mibi
- 99mtc-mibi
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03498183 | Phase 2/Phase 3 (Phase 3) | Jul 1, 2018 | University of Nantes |
| NCT00984191 | N/A | Mar 1, 2010 | Chulalongkorn University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chulalongkorn University | Academic/Hospital | 1 | 1 | 1 | 2010 |
| University of Nantes | Academic/Hospital | 1 | 1 | 1 | 2018 |
2 organizations
Page 1 / 1